Friedreich Ataxia Trial, Recruiting (NCT07095062)

Friedreich Ataxia Trial, Recruiting NCT07095062 Sponsor: IRCCS Eugenio Medea Condition: Friedreich Ataxia

Printed from Voxsanity (voxsanity.com.au) — NCT07095062 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Friedreich Ataxia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 8 and 60 years old
You have been diagnosed with Friedreich's ataxia through genetic testing, confirmed by having a specific type of gene change (called a GAA expansion) in both copies of the frataxin gene
Your ataxia symptoms are below a certain level of severity, as measured by a standard rating scale called SARA (with a score below 30)
You are able to complete a psychological and thinking skills assessment conducted in the Italian language

Who may not be able to join:

You are younger than 8 or older than 60 years old
You have a different type of ataxia, whether caused by an injury or illness (acquired ataxia) or a different genetic condition
Your ataxia symptoms are at or above a certain level of severity on the SARA rating scale (a score of 30 or higher)
You are not able to take part in a psychological and thinking skills assessment in Italian

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gabriella Paparella, Medical Doctor, IRCCS E. Medea / Associazione la Nostra Famiglia

Phone: +39 04389062

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07095062

Sponsor: IRCCS Eugenio Medea

Phase: Not Applicable

Status: Recruiting

Condition: Friedreich Ataxia

Trial contact: +39 04389062

More information: https://clinicaltrials.gov/study/NCT07095062

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 8 and 60 years old
You have been diagnosed with Friedreich's ataxia through genetic testing, confirmed by having a specific type of gene change (called a GAA expansion) in both copies of the frataxin gene
Your ataxia symptoms are below a certain level of severity, as measured by a standard rating scale called SARA (with a score below 30)
You are able to complete a psychological and thinking skills assessment conducted in the Italian language

Who may not be able to join:

You are younger than 8 or older than 60 years old
You have a different type of ataxia, whether caused by an injury or illness (acquired ataxia) or a different genetic condition
Your ataxia symptoms are at or above a certain level of severity on the SARA rating scale (a score of 30 or higher)
You are not able to take part in a psychological and thinking skills assessment in Italian

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS Eugenio Medea

Registry

ClinicalTrials.gov

Start date

7 July 2025

Est. completion

31 December 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Connectivity profile derived from HD-EEG in subjects with FRDA.; Functional activity derived from HD-EEG in subjects with FRDA.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov